Genodermatoses refer to a group of genetic skin diseases. These genetic skin conditions can have a variety of clinical presentations and vary in terms of severity, management, and prognosis. Although the exact prevalence of genodermatoses is unknown, some estimates suggest that up to 6-8% of all dermatologic visits are related to genetic skin disorders. Genodermatoses can be inherited in either an autosomal recessive, autosomal dominant, or X-linked manner. Autosomal recessive inheritance means that a mutation must be present in each of the two gene copies (one on each chromosome) to cause the disorder. Autosomal dominant inheritance is when only a single gene copy must carry the mutation, and X-linked inheritance is when an affected male typically passes the disorder on to their sons, while only an affected female may pass it on to her children. Diagnosis of these genetic skin conditions often relies on the various characteristic signs and symptoms, family history, and genetic testing. There is no single, straightforward test that can definitively diagnose all types of genodermatoses. In some cases, genetic testing can be used to identify the type of mutation present and thus confirm the diagnosis; however, this is not always possible or necessary. Treatment of these genetic skin diseases is often complex and depends on the specific disorder and its severity. Depending on the disorder, treatment may involve the use of medication, course of antibiotics, topical medications, laser treatments, or other modalities. Genetic counseling is often recommended for individuals with a family history of any type of genodermatoses. This is especially true in cases of autosomal dominant or X-linked genodermatoses, as genetic testing is more reliable in these cases than in cases of autosomal recessive disorders. Genetic counseling can provide individuals and family members with information on the disorder and potential preventive measures to avoid passing on the disorder to their future generations. In conclusion, genodermatoses are a wide array of genetic skin conditions that often require complex and individualized management. Although not all cases can be definitively diagnosed with genetic testing, finding the correct diagnosis is paramount to ensure appropriate treatment and preventative measures for the family.
Title : Personalized and precision dermatology through the view of biodesign-inspired translational & data-driven applications: Revolutionary skin treatments for every concern in clinical dermatology integrating skin care experts and consumers
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Personalized and precision medicine as a unique avenue to have the healthcare model renewed to secure the national biosafety: Advanced skincare solutions in individualized cosmetology, reconstructive plastic surgery and the modern beauty
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Unlocking the future of individualized cosmetics and reconstructive plastic surgery: Concepts and future prospects through the precision medical armamentarium tailored to the personalized DNA
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Modern non-invasive methods for in vivo assessment of skin
Georgios N Stamatas, SGS, France
Title : Paraneoplastic autoimmune multiorgan syndrome or PAMS: Paraneoplastic pemphigus revisited
Sergei A Grando, University of California Irvine, United States
Title : Antifungal resistance in dermatophytes: A growing concern
Jannatul Sharmin Joarder, Dhaka Medical College Hospital, Bangladesh